Urology billing hinges on bilateral kidney-stone surgery modifier 50, staged lithotripsy modifier 58, and ureteroscopy-stent bundling. Add TURP and TURBT global periods and prostate-cancer prior authorization — and general billers miss revenue on every procedure. MedFactor delivers urology-specific RCM that protects every claim.
From stone disease and endourology to oncology and prosthetics, we tailor billing to the coding rules of every urology subspecialty.
Ureteroscopy (52352), lithotripsy (52353/50590), stent placement (52332), and bilateral/staged modifier accuracy for stone surgery.
TURP (52601), laser vaporization, and laparoscopic prostatectomy (55866) with global-period and prior-auth management.
TURBT bladder-tumor resection (52240), kidney and prostate cancer surgery with staging and global-period tracking.
Prolapse repair, sling procedures, and reconstructive urology with implant capture and medical-necessity documentation.
Penile prosthesis (54405), infertility, and men's-health procedures with implant documentation and prior authorization.
Cryptorchidism, hypospadias, and pediatric urologic surgery with age-based coding and bilateral modifier rules.
Kidney-stone surgery turns on two modifier rules: bilateral stones treated in one session use modifier 50, while staged lithotripsy across separate sessions uses modifier 58. Miscoding either loses revenue or triggers denials on high-dollar ureteroscopy and ESWL cases.
When stones in both kidneys or both ureters are treated in the same operative session, modifier 50 reports the bilateral work.
When stone treatment is planned in stages across separate sessions — a second look or staged ureteroscopy — modifier 58 reports the related staged procedure.
Urology billing is governed by bilateral and staged modifiers, stent bundling, and global periods that general billing companies cannot navigate effectively.
Bilateral ureteroscopy or ESWL billed without modifier 50, losing the bilateral payment adjustment on high-dollar stone cases.
Second-look ureteroscopy denied as bundled into the first surgery's global period without modifier 58 for the staged procedure.
Ureteral stent (52332) denied as bundled into ureteroscopy (52352) when billed without supporting documentation for distinct placement.
Post-op visits and return procedures in the TURP/TURBT global billed separately without modifier 24/58, triggering denials.
Laparoscopic prostatectomy and advanced prostate procedures performed without prior authorization, denied and rarely appealed.
Penile prostheses and slings under-billed when implant device codes and supply documentation aren't captured at the case level.
Quick reference for the most frequently used codes in urology billing and coding.
| Code | Description | Common Use |
|---|---|---|
| 52000 | Cystoscopy, diagnostic | Bladder / urethral evaluation |
| 52352 | Cysto w/ ureteroscopy & stone removal | Ureteral stone treatment |
| 52353 | Cysto w/ ureteroscopy & lithotripsy | Intracorporeal lithotripsy |
| 52332 | Cysto w/ indwelling ureteral stent | Double-J stent placement |
| 50590 | Lithotripsy, ESWL | Extracorporeal shock-wave |
| 52601 | TURP (transurethral prostatectomy) | Benign prostatic hyperplasia |
| 52240 | TURBT (bladder tumor resection) | Bladder tumor removal |
| 55866 | Laparoscopic prostatectomy | Prostate cancer surgery |
| 54405 | Inflatable penile prosthesis | Men's health implant |
| 52344 | Ureteroscopy, diagnostic | Ureteral evaluation |
| Code | Description | Clinical Context |
|---|---|---|
| N20.0 | Calculus of kidney | Renal stone surgery |
| N20.1 | Calculus of ureter | Ureteral stone / ureteroscopy |
| N13.x | Hydronephrosis | Obstruction / stent indication |
| N40.x | Benign prostatic hyperplasia | TURP / BPH treatment |
| N81.x | Female genital prolapse | Reconstructive urology |
| N39.x | Urinary incontinence | Sling / incontinence procedures |
| C61 | Malignant neoplasm of prostate | Prostatectomy / oncology |
| C67.x | Malignant neoplasm of bladder | TURBT / bladder oncology |
| N35.x | Urethral stricture | Urethral surgery / dilation |
| R31.x | Hematuria | Diagnostic cystoscopy |
| Modifier | Description | Urology Application |
|---|---|---|
| 50 | Bilateral procedure | Bilateral ureteroscopy / ESWL for stones |
| 58 | Staged / related procedure in post-op | Staged lithotripsy / second-look ureteroscopy |
| 78 | Unplanned return to OR in post-op | Complication return in global period |
| 51 | Multiple procedures | Multiple urologic procedures same session |
| 25 | Separate E/M same day | E/M with same-day cystoscopy / procedure |
| 59 | Distinct procedural service | Distinct stent placement / separate procedures |
| 22 | Increased procedural service | Unusually complex stone / prostate surgery |
| 26 / TC | Professional / technical component | Urologic imaging interpretation |
Comprehensive revenue cycle management designed specifically for urology practices.
Specialty coders handle bilateral/staged stone modifiers, stent bundling, TURP/TURBT globals, and implant capture accurately.
Modifier 50/58 defense, NCCI bundling corrections, and appeals with procedural documentation for urology denials.
Pre-procedure authorization for laparoscopic prostatectomy, implants, advanced imaging, and staged stone surgery.
Prioritized follow-up on aged stone, prostate, and bladder-tumor claims with strategic payer escalation to maximize recovery.
Regular audits focused on modifier 50/58, NCCI stent bundling, global-period compliance, and implant documentation.
Real-time dashboards tracking stone-surgery volume, bilateral modifier capture, and procedure-level profitability.
Understanding the most common denial reasons is the first step to preventing them on stone and prostate claims.
Bilateral ureteroscopy or ESWL billed without modifier 50, losing the bilateral payment adjustment.
Modifier 50 applied per payer bilateral indicator and submission format on every bilateral stone case.
Second-look ureteroscopy denied as bundled into the first surgery's global without modifier 58.
Global-period tracking applies modifier 58 for planned staged stone procedures in the post-op global.
Ureteral stent (52332) denied as bundled into ureteroscopy under NCCI edits without distinct documentation.
NCCI-aware coding applies modifier 59 only where stent placement is genuinely distinct from ureteroscopy.
Laparoscopic prostatectomy performed without prior authorization, denied and rarely overturned on appeal.
Pre-procedure authorization with medical-necessity support before every advanced prostate surgery.
Identifying and plugging these common revenue leakage points can significantly improve your practice's bottom line.
Bilateral ureteroscopy/ESWL billed without modifier 50, losing the 150% bilateral payment.
Second-look stone surgery denied as bundled without modifier 58 in the global period.
Ureteral stent bundled or over-billed without correct modifier 59 for distinct placement.
Penile prosthesis and sling implant device codes not captured at the case level.
See how urology-specific revenue cycle management transforms your practice's financial performance.
A structured onboarding process designed to deliver measurable improvements within the first 90 days.
Review of urology billing operations, bilateral/staged modifier capture, and revenue cycle baseline.
EMR and surgery-system integration, dedicated urology billing team, and payer enrollment verification.
Full billing with real-time claim submission, modifier verification, and denial prevention protocols.
Performance review against baseline, workflow optimization, and documented revenue improvement.
How our urology-specific approach compares to in-house billing and general medical billing companies.
| Capability | In-House Team | General Billing Co. | MedFactor Urology |
|---|---|---|---|
| Bilateral modifier 50 for stones | Inconsistent | ✕ | ✓ |
| Staged modifier 58 for lithotripsy | ✕ | ✕ | ✓ |
| NCCI-aware stent bundling (mod 59) | ✕ | ✕ | ✓ |
| Prostate surgery prior authorization | Manual | Partial | ✓ |
| TURP / TURBT global-period tracking | ✕ | ✕ | ✓ |
| Implant & prosthesis device capture | Inconsistent | ✕ | ✓ |
| Bilateral & staged modifier reporting | ✕ | ✕ | ✓ |
| Stone-surgery economics analytics | ✕ | ✕ | ✓ |
| Dedicated urology billing team | ✕ | ✕ | ✓ |
Our team combines deep urology billing expertise with the technology and processes to deliver consistent, measurable results for stone, prostate, and oncology practices.
Discover exactly where your urology practice is losing revenue. Our no-obligation audit analyzes your bilateral/staged modifier compliance, stent bundling, and implant capture.
Real results from urology practices that partnered with MedFactor for specialty revenue cycle management.
A high-volume stone center was billing bilateral ureteroscopy without modifier 50 and dropping staged second-look procedures. MedFactor implemented bilateral-indicator checks and modifier 58 tracking, recovering substantial surgical revenue in six months.
A urologic oncology practice was losing stent revenue to NCCI bundling and post-op visits to global periods. MedFactor implemented modifier 59 and 24/58 protocols, recovering revenue that had been silently denied.
A men's-health practice was under-billing penile prosthesis cases by missing implant device codes. MedFactor implemented case-level device capture and prior auth, protecting implant procedure revenue.
No matter where your urology practice operates, our team understands the payer landscape and regulatory requirements in your region.
Common questions from urology practices considering MedFactor's specialty RCM services.
When stones in both kidneys or both ureters are treated in the same operative session — for example bilateral ureteroscopy (52352) or bilateral ESWL (50590) — modifier 50 is appended and most payers pay 150% of the fee schedule. Not all urology codes have a bilateral indicator of 1, so we verify the indicator for each stone-procedure code before applying modifier 50, and we follow the payer's submission format (one line with modifier 50, or two per-side lines). Bilateral stone surgery billed without modifier 50 is the most common way high-dollar ureteroscopy revenue is lost.
When stone treatment is planned in stages across separate sessions — a planned second-look ureteroscopy or staged lithotripsy (52353) following the initial procedure — modifier 58 reports the related, staged procedure performed during the first surgery's post-operative global period. Modifier 58 allows the staged procedure to be paid separately rather than bundled into the original surgery's global package. An unplanned return to the operating room for a complication uses modifier 78 instead. We track global periods across every staged stone case so the second-look is billed correctly.
NCCI procedure-to-procedure edits often bundle ureteral stent placement (52332) into ureteroscopy (52352/52353) when performed at the same session on the same side, because stent placement is considered part of the ureteroscopic work. When stent placement is genuinely distinct — for example a stent placed without ureteroscopy, or for a separate clinical indication — modifier 59 (distinct procedural service) can override the edit. We apply NCCI edits before submission so the stent is correctly bundled where appropriate and billed with modifier 59 only where genuinely distinct, preventing denials and the compliance risk of overriding edits unnecessarily.
TURP (52601) and TURBT (52240) carry post-operative global periods during which routine follow-up visits are bundled into the surgical payment. A staged or planned related procedure in the global uses modifier 58, an unplanned return to the OR uses modifier 78, and an unrelated E/M visit in the global uses modifier 24. For bladder tumor surveillance cystoscopies that follow a TURBT, the timing and indication determine whether the visit is bundled or separately billable. We track every TURP/TURBT global period so follow-up and return procedures are billed with the correct modifier.
Advanced prostate procedures — laparoscopic prostatectomy (55866), robotic-assisted prostatectomy, and some BPH laser treatments — frequently require prior authorization from commercial payers, with documentation of cancer staging, failed conservative care, or specific clinical criteria. We obtain authorization before the procedure with the supporting medical-necessity documentation, because prostate surgery performed without authorization is denied and rarely overturned on appeal. We track authorization status per case so no advanced prostate procedure is scheduled without coverage confirmed.
Penile prosthesis (54405), urinary slings, and artificial urinary sphincters are billed with the procedure code plus the implant device and supply codes captured at the case level, along with prior authorization for most commercial payers. Under-billing happens when the implant device codes are not captured separately from the procedure, or when the device cost isn't documented. We capture the procedure, the device, and the supplies for every implant case, with prior authorization obtained in advance, so the full implant procedure revenue — including the device — is recovered.
MedFactor applies the same code-level precision across the full practice spectrum. See how we bill these related specialties.
CPT®, ICD-10, HCPCS, and modifier codes referenced on this page reflect the current code sets and are subject to annual updates — always verify against the current-year fee schedule before submission. KPIs and case-study figures shown are representative benchmarks, not guarantees of individual practice results.
Your urology practice deserves billing partners who know bilateral modifier 50, staged modifier 58, and NCCI stent bundling — and code every claim correctly. Let MedFactor show you what specialty RCM can do.